Order Article Reprints

Kim US, Park JW, Park ES, Bang JS, Jung TW, Kim D-S, Abd El-Aty AM, Lee JH, Jeong JH. The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis. Pharmaceutics. 2020; 12(8):750. https://doi.org/10.3390/pharmaceutics12080750

Kim, Ui Seok, Jin Woo Park, Eon Sub Park, Joon Seok Bang, Tae Woo Jung, Dong-Seok Kim, A. M. Abd El-Aty, Jong Hyuk Lee, and Ji Hoon Jeong. 2020. "The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis" Pharmaceutics 12, no. 8: 750. https://doi.org/10.3390/pharmaceutics12080750

Kim, U. S., Park, J. W., Park, E. S., Bang, J. S., Jung, T. W., Kim, D.-S., Abd El-Aty, A. M., Lee, J. H., & Jeong, J. H. (2020). The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis. Pharmaceutics, 12(8), 750. https://doi.org/10.3390/pharmaceutics12080750